UnitedHealth Group Incorporated (UNH)
UnitedHealth's former employees probed by DOJ as part of billing practices investigation
Former employees at UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) are being questioned by the US Department of Justice (DOJ) as part of its ongoing criminal investigation into the company's Medicare Advantage billing practices, according to a Wall Street Journal report. Prosecutors from the DOJ's healthcare-fraud unit, along with the FBI and the Department of Health and Human Services' Office of Inspector General, have been interviewing former doctors, nurses, and other staff about how UnitedHealth deployed medical personnel to collect diagnoses that increased Medicare reimbursements, the publication reported.
Prosecutors Question Doctors About UnitedHealth's Medicare Billing Practices
Justice Department prosecutors recently interviewed former employees about company practices that boost federal payments.
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
UnitedHealth Group (UNH) concluded the recent trading session at $307.7, signifying a +1.31% move from its prior day's close.
UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector
UNH and peers tumble as Medicaid cuts, enrollment shifts and rising costs shake up the managed care sector.
UnitedHealth: My Uncomfortable Buy With Possible Upside Despite All The Red Flags
UnitedHealth Group faces multiple headwinds: soaring medical costs, leadership changes, regulatory scrutiny, and reputational issues—creating significant uncertainty. Despite these challenges, the stock is trading at a steep discount, with a forward P/E nearly 30% below its 5-year average, pricing in substantial downside. If operational and financial issues stabilize, UNH could see significant upside, potentially doubling in value as fundamentals normalize and margins recover.
Is UnitedHealth Group (UNH) a Buy Now After These 2 Huge Developments?
Key Points in This Article: UnitedHealth Group (UNH), the largest U.S.
UnitedHealth: Buy Or Sell UNH Stock At $325?
UnitedHealth's stock (NYSE:UNH) has undergone a noticeable decline, decreasing from a peak of around $600 in April to about $275 in May, and then making a slight recovery to $325. This drop followed the company's announcement of disappointing Q1 results, the later retraction of its earnings forecast, and sudden shifts in top management.
Just like UnitedHealth, this healthcare giant tumbles after financial shocker
Shares of Centene (NYSE: CNC) have tumbled more than 20% after the healthcare giant stunned investors by withdrawing its full-year financial guidance.
UnitedHealth: Cheap, But Is It Worth It?
UnitedHealth Group operates through UnitedHealthcare (insurance) and Optum (health services, tech, pharmacy), making it a global healthcare leader. Shares have plummeted over 40% in 2025, reflecting negative sentiment and recent underperformance. Q1 earnings were mixed: some growth areas, but also notable shortfalls and missed targets.
UnitedHealth Dropped From Russell Growth: How to Trade UNH Now
UNH's removal from key Russell growth indices caps a turbulent stretch marked by steep losses, rising costs and regulatory woes.
UnitedHealth: Pivotal Changes Underway
UnitedHealth: Pivotal Changes Underway
This Dividend Growth Stock Is Down 50%. Back Up the Truck or Put It in Park and Wait?
Key Points in This Article: UnitedHealth Group (UNH) has plummeted nearly 52% from its April peak, driven by a rare series of cataclysmic events.
